GSK-A1 is a selective type III phosphatidylinositol 4-kinase PI4KA (PI4KIIIalpha) inhibitor with a pIC50 of 8.5-9.8. GSK-A1 inhibits PtdIns(4,5)P2 resynthesis with an IC50 of about 3 nM. GSK-A1 potently decreases the levels of PtdIns(4)P with a negligible effect on PtdIns(4,5)P2. GSK-A1 has the potential for anti-hepatitis C virus (HCV) research[1].
Molecular Weight:
574.63
Purity:
99.04
CAS Number:
[1416334-69-4]
Formula:
C29H27FN6O4S
Target:
HCV,PI4K
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted